Debra international – Research Grants for Epidermolysis bullosa

DEBRA Research gGmbH, a global non-profit organization dedicated to advancing research and drug development for those affected by Epidermolysis bullosa (EB), launches a call for Basic Science and Research Grants. This funding opportunity supports high-quality, original research projects focused on inherited forms of EB. DEBRA Research invites applications from researchers committed to driving meaningful scientific and clinical progress that can improve the quality of life for those living with this devastating genetic condition.

What We Are Looking For

Projects that aim to:

• Advance scientific understanding of EB at the molecular and systemic levels
• Develop disease-modifying or curative therapies
• Prevent or treat severe consequences of EB
• Improve clinical care and symptom relief
• Overcome infrastructure, data, and technological barriers to enable therapy access

Eligible Applicants

Academic researchers, non-profit organizations, hospitals, and mixed international consortia are welcome to apply. We strongly encourage collaborative, interdisciplinary proposals that bring novel tools, technologies, and approaches to the field – including but not limited to cell/gene therapies, small molecules, biologics, medical devices, and data-driven (in silico) approaches.

Application Process

The process follows a two-stage application model:

1. Expression of Interest (EOI)

As a first step, submit a concise outline using the EOI template (see website). EOIs will be assessed for their scientific, clinical, and commercial potential.

2. Full Proposal (by invitation only)

In the second step, the shortlisted applicants will be invited to submit a full proposal via our grant management system (Grant Tracker). This stage includes peer review, a rebuttal opportunity, and a pitch presentation.

Key Dates – At a Glance

For templates, further eligibility details, and guidance, visit www.debra-research.org or contact grants@debra-research.org.